CTL epitopes for influenza A including the H5N1 bird flu; genome-, pathogen-, and HLA-wide screening.
about
Immune mechanisms of protection: can adjuvants rise to the challenge?Multiple viral ligands naturally presented by different class I molecules in transporter antigen processing-deficient vaccinia virus-infected cellsThe influenza virus enigmaMemory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individualsThe unmet need in the elderly: how immunosenescence, CMV infection, co-morbidities and frailty are a challenge for the development of more effective influenza vaccinesStructure of a SARS coronavirus-derived peptide bound to the human major histocompatibility complex class I molecule HLA-B*1501Crystal Structure of Swine Major Histocompatibility Complex Class I SLA-1*0401 and Identification of 2009 Pandemic Swine-Origin Influenza A H1N1 Virus Cytotoxic T Lymphocyte Epitope PeptidesHLA class I binding 9mer peptides from influenza A virus induce CD4 T cell responsesDendritic cells reveal a broad range of MHC class I epitopes for HIV-1 in persons with suppressed viral load on antiretroviral therapyImmunogenicity of HLA Class I and II Double Restricted Influenza A-Derived PeptidesAdaptive immune responses to booster vaccination against yellow fever virus are much reduced compared to those after primary vaccinationSynthetic Long Peptide Influenza Vaccine Containing Conserved T and B Cell Epitopes Reduces Viral Load in Lungs of Mice and Ferrets.Infection of HLA-DR1 transgenic mice with a human isolate of influenza a virus (H1N1) primes a diverse CD4 T-cell repertoire that includes CD4 T cells with heterosubtypic cross-reactivity to avian (H5N1) influenza virus.Targets for the induction of protective immunity against influenza a viruses.Immunization with a hemagglutinin-derived synthetic peptide formulated with a CpG-DNA-liposome complex induced protection against lethal influenza virus infection in mice.Influenza nucleoprotein delivered with aluminium salts protects mice from an influenza A virus that expresses an altered nucleoprotein sequence.T-cell epitope prediction: rescaling can mask biological variation between MHC molecules.Identification of CD8+ T cell epitopes in the West Nile virus polyprotein by reverse-immunology using NetCTL.NetCTLpan: pan-specific MHC class I pathway epitope predictionsHLA-restricted NY-ESO-1 peptide immunotherapy for metastatic castration resistant prostate cancerMultiple, non-conserved, internal viral ligands naturally presented by HLA-B27 in human respiratory syncytial virus-infected cellsState of the art and challenges in sequence based T-cell epitope predictionIdentification of prostate-specific G-protein coupled receptor as a tumor antigen recognized by CD8(+) T cells for cancer immunotherapy.An assessment on epitope prediction methods for protozoa genomes.Identification of special AT-rich sequence binding protein 1 as a novel tumor antigen recognized by CD8+ T cells: implication for cancer immunotherapyDiversity of natural self-derived ligands presented by different HLA class I molecules in transporter antigen processing-deficient cells.Vaccine adjuvants aluminum and monophosphoryl lipid A provide distinct signals to generate protective cytotoxic memory CD8 T cells.Identification and HLA-tetramer-validation of human CD4+ and CD8+ T cell responses against HCMV proteins IE1 and IE2.A common minimal motif for the ligands of HLA-B*27 class I molecules.GLA-SE, a synthetic toll-like receptor 4 agonist, enhances T-cell responses to influenza vaccine in older adults.Predictions versus high-throughput experiments in T-cell epitope discovery: competition or synergy?Immunosenescence and Challenges of Vaccination against Influenza in the Aging Population.The Length Distribution of Class I-Restricted T Cell Epitopes Is Determined by Both Peptide Supply and MHC Allele-Specific Binding Preference.The evolution of human influenza A viruses from 1999 to 2006: a complete genome study.Natural HLA-B*2705 protein ligands with glutamine as anchor motif: implications for HLA-B27 association with spondyloarthropathy.A maximum likelihood method for detecting directional evolution in protein sequences and its application to influenza A virus.Epitope-based vaccine against influenza.Cross-reactive human B cell and T cell epitopes between influenza A and B viruses.B cells promote resistance to heterosubtypic strains of influenza via multiple mechanisms.Genome-wide screening of human T-cell epitopes in influenza A virus reveals a broad spectrum of CD4(+) T-cell responses to internal proteins, hemagglutinins, and neuraminidases.
P2860
Q21245319-0F4B6EB2-5C6B-4960-84FD-94C90AACCEB8Q24294775-4AA437E4-93F9-4663-9C0B-90BA4D05D802Q24616614-C2D5F3BE-524F-4AAF-B22B-77E79DA57EF3Q24648051-F7029483-C216-49A7-9642-82EF6CB01D3AQ27025076-C0627B21-7342-4E1F-9CFF-458ED10C498BQ27650782-FD397526-25CE-4834-8CD6-833B0F679112Q27673392-B0B4301D-12A6-4326-A7EB-2576D4C43FCFQ28473871-64EBE011-CBAF-4240-963D-C9B21EA3C10BQ28475576-46F43DE5-2C61-446C-9A90-42AA71A03D1CQ28552077-FC307F9A-BE1F-439B-BFA6-CBD12876957EQ29274569-9EA46043-EC68-401E-8976-6A95D340DA9CQ30375348-E9140B16-EE10-4382-BCE6-487E6A431E30Q30376369-C11DB984-597A-4B28-A73B-62D734DD2AF7Q30408100-4D8AA88D-1921-446C-9995-093C24B6B6C9Q30423481-489A8278-F8D6-4C4D-A52C-E31F011465EFQ30429719-AF31497F-6B5E-4138-BC37-9262620F65FFQ30486286-7919BC72-88D5-46BF-BDE6-8F3C181616B6Q33697909-ECE547A6-E8F5-45D8-B698-F6119F8AE509Q33873269-40BD7F7D-EDD8-4B7C-9727-4AD27719AFF2Q33909892-7602A332-B285-4488-A4B9-C0978B354EF4Q34122073-4F449999-DEC8-43C6-878C-3E00A436D9FDQ34312500-2AF73618-2C52-4965-87F0-1AF0E08508C5Q34429991-B528D6C5-5107-4590-A121-AA5E2171F9F9Q34484256-3CA1477E-0866-41C9-870C-FE04C424381DQ34599387-CC5ECB1F-F3BC-46B0-AF4E-E535B9E7FCE1Q34650773-CE519B3E-B710-43F3-AD9D-A02C290DC699Q34977848-A76B2FF4-E508-4DF2-83A9-4EAC4DB5BD1DQ35156297-681AF9BF-D53A-4DB2-9AB7-2B617D9533FDQ35288793-E2D64D93-6A91-4411-B0AD-23DEE6E56EF6Q35669044-D19C4FDF-5307-4293-B0A3-DA2AB9E1AA1DQ35813585-1FB1C775-6CE5-49E9-97E3-776BA641C979Q35874111-030FF26A-C516-47E7-AC63-0F6E1C54ADE1Q36553815-22215330-DB93-4477-A683-CDAB083898EDQ36557808-6C82031C-D00F-4F1F-B9AA-17C8F4D88F16Q36760435-1A8A8D3D-57FB-4E57-BF00-F49D2D554C1FQ36836676-0D82233F-5C2D-4B36-849D-563006AEE687Q37012089-0545EDAB-8E5C-486B-A560-F7E68B10267AQ37053710-0FEDA03C-E95D-4C44-A4BE-1708E55BA6B6Q37267195-18C4E16F-597A-481A-8B23-E117FB590465Q37398991-E980F014-2977-4381-B382-066C577944D7
P2860
CTL epitopes for influenza A including the H5N1 bird flu; genome-, pathogen-, and HLA-wide screening.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
CTL epitopes for influenza A i ...... ogen-, and HLA-wide screening.
@en
CTL epitopes for influenza A i ...... ogen-, and HLA-wide screening.
@nl
type
label
CTL epitopes for influenza A i ...... ogen-, and HLA-wide screening.
@en
CTL epitopes for influenza A i ...... ogen-, and HLA-wide screening.
@nl
prefLabel
CTL epitopes for influenza A i ...... ogen-, and HLA-wide screening.
@en
CTL epitopes for influenza A i ...... ogen-, and HLA-wide screening.
@nl
P2093
P50
P1433
P1476
CTL epitopes for influenza A i ...... ogen-, and HLA-wide screening.
@en
P2093
Claus Lundegaard
Gustav Røder
Jørgen Rosenkvist
Kasper Lamberth
Mette V Larsen
Mikkel Harndahl
Mingjun Wang
Mogens H Claesson
Morten H Dziegiel
Sheila T Tang
P304
P356
10.1016/J.VACCINE.2006.12.038
P407
P577
2006-12-29T00:00:00Z